Efficacy of Botox in Patients With Idiopathic Clubfoot

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00152334
First received: September 7, 2005
Last updated: February 27, 2014
Last verified: February 2014
  Purpose

The purpose of this study was to determine the efficacy of adding Botox injection to serial manipulations and castings in patients with clubfoot. The study hypothesis was that the use of Botox in the setting of serial manipulations and castings is an effective treatment for clubfoot.


Condition Intervention
Idiopathic Clubfoot (Talipes Equinovarus)
Drug: Botox

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment of Idiopathic Clubfoot Utilizing Botulinum Toxin A: A New Treatment for Correction

Resource links provided by NLM:


Further study details as provided by University of British Columbia:

Primary Outcome Measures:
  • The rate of successful clubfoot correction from a single Botox injection. This coincides with entrance into Boots and Bars. This was measured 8 weeks following injection. [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary outcomes of the study as outlined in protocol (include time of measurement) [ Time Frame: See protocol ] [ Designated as safety issue: No ]
  • Secondary Outcomes: Patient outcomes collected at every patient visit including: [ Time Frame: See protocol ] [ Designated as safety issue: No ]
  • 1. Ankle range of motion (dorsiflexion and plantarflexion) (collected at every visit) [ Time Frame: See protocol ] [ Designated as safety issue: No ]
  • 2. Heel Bisector Scores (collected at every visit) [ Time Frame: See protocol ] [ Designated as safety issue: No ]
  • 3. Pedobarographs (every 6 months from 18 months to 5 years) [ Time Frame: See protocol ] [ Designated as safety issue: No ]
  • Gait Analysis (every 2 years from 5 years of age until skeletal maturity) [ Time Frame: See protocol ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: September 2005
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Botox
    All patients meeting the inclusion criteria will undergo manipulation and casting until hindfoot stall is encountered. Hindfoot stall is defined as forefoot abduction to 60 degrees but persistence of hindfoot equinus. At hindfoot stall, subjects received Botox injections at 10 IU/kg into the gastrosoleus muscle complex. Following injections, subjects were recasted.
Detailed Description:

All patients meeting the inclusion criteria will undergo manipulation and casting until hindfoot stall is encountered. Hindfoot stall is defined as forefoot abduction to 60 degrees but persistence of hindfoot equinus. At hindfoot stall, subjects received Botox injections at 10 IU/kg into the gastrosoleus muscle complex. Following injections, subjects were recasted.

  Eligibility

Ages Eligible for Study:   up to 2 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Children presenting with idiopathic clubfoot/feet at BC Children's Hospital
  2. Children ranging in age from 1 day to 2 years old at initial treatment Children who have had previous intervention for their clubfoot (methods including surgery, Ponseti method, Kite method, physical therapy method) and had a clubfoot recurrence requiring re-intervention
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00152334

Locations
Canada, British Columbia
BC Children's Hospital, Department of Orthopaedics
Vancouver, British Columbia, Canada, V6H 3V4
Sponsors and Collaborators
University of British Columbia
Investigators
Principal Investigator: Christine Alvarez, PhD University of British Columbia
  More Information

No publications provided

Responsible Party: University of British Columbia
ClinicalTrials.gov Identifier: NCT00152334     History of Changes
Other Study ID Numbers: C01-0210, W01-0057
Study First Received: September 7, 2005
Last Updated: February 27, 2014
Health Authority: Canada: Health Canada

Keywords provided by University of British Columbia:
Efficacy study
assessment of patient outcomes following treatment

Additional relevant MeSH terms:
Clubfoot
Equinus Deformity
Congenital Abnormalities
Foot Deformities
Foot Deformities, Acquired
Foot Deformities, Congenital
Limb Deformities, Congenital
Lower Extremity Deformities, Congenital
Musculoskeletal Abnormalities
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on October 21, 2014